Xgenera raised £3.5M to develop its miONCO multi-cancer early detection test using microRNA blood analysis.
Xgenera is developing miONCO, a transformative test for the early detection of multiple cancers, aiming to catch cancer earlier and save lives
Xgenera is developing miONCO, a transformative test for the early detection of multiple cancers, aiming to catch cancer earlier and save lives.